Cargando…

Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry

PURPOSE: The purpose of this study was to define the nature and extent of sensitivity loss using chromatic perimetry in diabetics who have mild or no retinopathy. METHODS: Thirty-four individuals with type II diabetes mellitus who have mild nonproliferative diabetic retinopathy (MDR; N = 17) or no d...

Descripción completa

Detalles Bibliográficos
Autores principales: McAnany, J. Jason, Park, Jason C., Lim, Jennifer I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907378/
https://www.ncbi.nlm.nih.gov/pubmed/36734963
http://dx.doi.org/10.1167/iovs.64.2.8
_version_ 1784884162832891904
author McAnany, J. Jason
Park, Jason C.
Lim, Jennifer I.
author_facet McAnany, J. Jason
Park, Jason C.
Lim, Jennifer I.
author_sort McAnany, J. Jason
collection PubMed
description PURPOSE: The purpose of this study was to define the nature and extent of sensitivity loss using chromatic perimetry in diabetics who have mild or no retinopathy. METHODS: Thirty-four individuals with type II diabetes mellitus who have mild nonproliferative diabetic retinopathy (MDR; N = 17) or no diabetic retinopathy (NDR; N = 17) and 15 visually normal, non-diabetic controls participated. Sensitivity was assessed along the horizontal visual field meridian using an Octopus 900 perimeter. Measurements were performed under light- and dark-adapted conditions using long-wavelength (red) and short-wavelength (blue) Goldmann III targets. Cumulative defect curves (CDCs) were constructed to determine whether field sensitivity loss was diffuse or localized. RESULTS: Sensitivity was reduced significantly under light-adapted conditions for both stimulus colors for the NDR (mean defect ± SEM = −2.1 dB ± 0.6) and MDR (mean defect ± SEM = −4.0 dB ± 0.7) groups. Sensitivity was also reduced under dark-adapted conditions for both stimulus colors for the NDR (mean defect ± SEM = −1.9 dB ± 0.7) and MDR (mean defect ± SEM = −4.5 ± 1.0 dB) groups. For both diabetic groups, field loss tended to be diffuse under light-adapted conditions (up to 6.9 dB loss) and localized under dark-adapted conditions (up to 15.4 dB loss). CONCLUSIONS: Visual field sensitivity losses suggest neural abnormalities in early stage diabetic eye disease and the pattern of the sensitivity losses differed depending on the adaptation conditions. Chromatic perimetry may be useful for subtyping individuals who have mild or no diabetic retinopathy and for better understanding their neural dysfunction.
format Online
Article
Text
id pubmed-9907378
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-99073782023-02-08 Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry McAnany, J. Jason Park, Jason C. Lim, Jennifer I. Invest Ophthalmol Vis Sci Visual Psychophysics and Physiological Optics PURPOSE: The purpose of this study was to define the nature and extent of sensitivity loss using chromatic perimetry in diabetics who have mild or no retinopathy. METHODS: Thirty-four individuals with type II diabetes mellitus who have mild nonproliferative diabetic retinopathy (MDR; N = 17) or no diabetic retinopathy (NDR; N = 17) and 15 visually normal, non-diabetic controls participated. Sensitivity was assessed along the horizontal visual field meridian using an Octopus 900 perimeter. Measurements were performed under light- and dark-adapted conditions using long-wavelength (red) and short-wavelength (blue) Goldmann III targets. Cumulative defect curves (CDCs) were constructed to determine whether field sensitivity loss was diffuse or localized. RESULTS: Sensitivity was reduced significantly under light-adapted conditions for both stimulus colors for the NDR (mean defect ± SEM = −2.1 dB ± 0.6) and MDR (mean defect ± SEM = −4.0 dB ± 0.7) groups. Sensitivity was also reduced under dark-adapted conditions for both stimulus colors for the NDR (mean defect ± SEM = −1.9 dB ± 0.7) and MDR (mean defect ± SEM = −4.5 ± 1.0 dB) groups. For both diabetic groups, field loss tended to be diffuse under light-adapted conditions (up to 6.9 dB loss) and localized under dark-adapted conditions (up to 15.4 dB loss). CONCLUSIONS: Visual field sensitivity losses suggest neural abnormalities in early stage diabetic eye disease and the pattern of the sensitivity losses differed depending on the adaptation conditions. Chromatic perimetry may be useful for subtyping individuals who have mild or no diabetic retinopathy and for better understanding their neural dysfunction. The Association for Research in Vision and Ophthalmology 2023-02-03 /pmc/articles/PMC9907378/ /pubmed/36734963 http://dx.doi.org/10.1167/iovs.64.2.8 Text en Copyright 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Visual Psychophysics and Physiological Optics
McAnany, J. Jason
Park, Jason C.
Lim, Jennifer I.
Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
title Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
title_full Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
title_fullStr Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
title_full_unstemmed Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
title_short Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
title_sort visual field abnormalities in early-stage diabetic retinopathy assessed by chromatic perimetry
topic Visual Psychophysics and Physiological Optics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907378/
https://www.ncbi.nlm.nih.gov/pubmed/36734963
http://dx.doi.org/10.1167/iovs.64.2.8
work_keys_str_mv AT mcananyjjason visualfieldabnormalitiesinearlystagediabeticretinopathyassessedbychromaticperimetry
AT parkjasonc visualfieldabnormalitiesinearlystagediabeticretinopathyassessedbychromaticperimetry
AT limjenniferi visualfieldabnormalitiesinearlystagediabeticretinopathyassessedbychromaticperimetry